Melagenix

Developer of molecular diagnostic tests to detect skin cancer

placeCologne, North Rhine Westphalia, Germany calendar_todayFounded 2017 groups9 employees language melagenix.info

Registered entities

Investor mix

8 investors on record; lead investors include BayBG Venture Capital.

Investor typeCountShare
Venture capital338%
Private equity113%
Other / undisclosed450%
Coming soon